This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie policy for more information on the cookies we use and how to delete or block them.

Ok, Got It
News, stories and opinions for the business innovators of the world.

World first imaging incubator uses unconventional approach to monitor embryos

Roger LangsdonMarketing Director

Genea Biomedx has created an incubation instrument with time lapse photography, which allows scientists and potential parents to watch their embryos grow in their first crucial few days.

There are over 1.5 million IVF cycles a year helping people fulfill their dream of having a family. One of the challenges of IVF is the need for embryologists to remove embryos from the incubator to review them under the microscope, taking them out of the ideal growth conditions for short periods of time.

Genea Biomedx asked the simple question: What if we could integrate a low-cost imaging solution within the incubator itself, thereby eliminating the need to remove the embryo from its safe environment for grading? The answer to this challenge would not lie in conventional IVF technology.

Working with Planet Innovation, Genea Biomedx bucked the market trend of developing a bigger, more expensive microscope. Instead, it looked beyond the medical industry and discovered a low cost imaging system that could achieve an image quality suitable for embryologists to assess key embryo features.

The imaging incubator, known as Geri, is different to other incubators on the market in that it combines a low-cost multi-camera imaging system with individually controlled multi-patient incubator chambers. This means that embryologist can assess an embryo’s development by observing high-quality time-lapse images while the embryo remains safely contained within the regulated environment of an embryonic incubator. All this was made possible through the unorthodox approach of integrating high quality camera technology from non-medical industries.


Update: National broadcaster, 7 News, reported on the story here.

SHARE THIS ARTICLE:
Roger Langsdon Marketing Director
Roger Langsdon

Roger is the Marketing Director at Planet Innovation and a specialist marketing and communications professional with a focus on growing an organization’s reputation and revenue through strategic marketing and high-impact communications.

Roger Langsdon
Topics.

Sign up for the Perspectives newsletter:

A roundup of the latest news and opinions from PI.

Related Articles.

Lumos Diagnostics raises AU$25m in oversubscribed pre-IPO capital raise

News

Lumos Diagnostics, a rapid point-of-care diagnostics company spun out of Planet Innovation, has closed an oversubscribed AU$25 million pre-IPO capital raise, ahead of an anticipated 2021 Australian Securities Exchange (ASX) listing.

Stuart Elliott responds to Australian Government’s Modern Manufacturing Strategy

Manufacturing

The COVID-19 pandemic has brought to light the gaps in Australia’s manufacturing capacity, but has also highlighted its potential. We’re glad to see the Australian Government focusing on medical manufacturing because we know we can compete globally in this sector.

Levitas Bio partners with PI to develop and manufacture the world’s first label-free cell separation platform

Product Dev

Silicon Valley start-up Levitas Bio has launched the world’s first label-free cell separation platform, the LeviCell™.

PI and Lumos pick up top Medical Design and Engineering Awards for rapid diagnostic development platform

Design

Planet Innovation and Lumos Diagnostics have won two awards at the 2020 Good Design Awards, including a Good Design Award Gold accolade for Lumos’s Leelu Reader.

News

Lumos Diagnostics raises AU$25m in oversubscribed pre-IPO capital raise

Lumos Diagnostics, a rapid point-of-care diagnostics company spun out of Planet Innovation, has closed an oversubscribed AU$25 million pre-IPO capital raise, ahead of an anticipated 2021 Australian Securities Exchange (ASX) listing.